Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease
- PMID: 33277246
- PMCID: PMC7717916
- DOI: 10.1126/sciadv.abb8680
Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease
Abstract
Myelin degeneration and white matter loss resulting from oligodendrocyte (OL) death are early events in Alzheimer's disease (AD) that lead to cognitive deficits; however, the underlying mechanism remains unknown. Here, we find that mature OLs in both AD patients and an AD mouse model undergo NLR family pyrin domain containing 3 (NLRP3)-dependent Gasdermin D-associated inflammatory injury, concomitant with demyelination and axonal degeneration. The mature OL-specific knockdown of dynamin-related protein 1 (Drp1; a mitochondrial fission guanosine triphosphatase) abolishes NLRP3 inflammasome activation, corrects myelin loss, and improves cognitive ability in AD mice. Drp1 hyperactivation in mature OLs induces a glycolytic defect in AD models by inhibiting hexokinase 1 (HK1; a mitochondrial enzyme that initiates glycolysis), which triggers NLRP3-associated inflammation. These findings suggest that OL glycolytic deficiency plays a causal role in AD development. The Drp1-HK1-NLRP3 signaling axis may be a key mechanism and therapeutic target for white matter degeneration in AD.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Figures
Similar articles
-
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.J Alzheimers Dis. 2021;82(4):1769-1783. doi: 10.3233/JAD-210400. J Alzheimers Dis. 2021. PMID: 34219728 Free PMC article.
-
Mdivi-1 alleviates atopic dermatitis through the inhibition of NLRP3 inflammasome.Exp Dermatol. 2021 Dec;30(12):1734-1744. doi: 10.1111/exd.14412. Epub 2021 Jul 5. Exp Dermatol. 2021. PMID: 34133800
-
Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.Antioxid Redox Signal. 2019 Apr 10;30(11):1411-1431. doi: 10.1089/ars.2017.7440. Epub 2018 Apr 25. Antioxid Redox Signal. 2019. PMID: 29634349
-
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.Neurochem Res. 2020 Nov;45(11):2560-2572. doi: 10.1007/s11064-020-03121-z. Epub 2020 Sep 14. Neurochem Res. 2020. PMID: 32929691 Review.
-
Neuroinflammation in Alzheimer's Disease: Focus on NLRP1 and NLRP3 Inflammasomes.Curr Protein Pept Sci. 2021;22(8):584-598. doi: 10.2174/1389203722666210916141436. Curr Protein Pept Sci. 2021. PMID: 34530705 Review.
Cited by
-
Mitochondrial modulation treating postoperative cognitive dysfunction neuroprotection via DRP1 inhibition by Mdivi1.Sci Rep. 2024 Oct 30;14(1):26155. doi: 10.1038/s41598-024-75548-1. Sci Rep. 2024. PMID: 39478015 Free PMC article.
-
Meningeal lymphatic function promotes oligodendrocyte survival and brain myelination.Immunity. 2024 Oct 8;57(10):2328-2343.e8. doi: 10.1016/j.immuni.2024.08.004. Epub 2024 Aug 31. Immunity. 2024. PMID: 39217987
-
Anti-Neuroinflammatory Effects of Ginkgo biloba Extract EGb 761 in LPS-Activated BV2 Microglial Cells.Int J Mol Sci. 2024 Jul 25;25(15):8108. doi: 10.3390/ijms25158108. Int J Mol Sci. 2024. PMID: 39125680 Free PMC article.
-
Respiratory infection with influenza A virus delays remyelination and alters oligodendrocyte metabolism.iScience. 2024 Jul 5;27(8):110464. doi: 10.1016/j.isci.2024.110464. eCollection 2024 Aug 16. iScience. 2024. PMID: 39104416 Free PMC article.
-
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.Front Aging Neurosci. 2024 May 14;16:1400544. doi: 10.3389/fnagi.2024.1400544. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38808033 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- K08 AG065463/AG/NIA NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- S10 OD028614/OD/NIH HHS/United States
- R21 NS107897/NS/NINDS NIH HHS/United States
- DP2 HD084068/HD/NICHD NIH HHS/United States
- S10 OD026882/OD/NIH HHS/United States
- R56 AG062272/AG/NIA NIH HHS/United States
- R01 AG061388/AG/NIA NIH HHS/United States
- R01 AG065240/AG/NIA NIH HHS/United States
- P30 AG062428/AG/NIA NIH HHS/United States
- R01 NS115903/NS/NINDS NIH HHS/United States
- P30 EY011373/EY/NEI NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- R01 AG057557/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
